Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in progressive ischemic stroke

Journal of Stroke and Cerebrovascular Diseases

Volumn 9, Issue 2 SUPPL., 2000, Pages 183-184

  Wong, W J ^a   Lo, Y K ^a   Sheng, W Y ^a   Hu, H H ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TICLOPIDINE;

ANTICOAGULANT THERAPY; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; GLASGOW COMA SCALE; HUMAN; NEUROLOGIC EXAMINATION; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE COUNT;

EID: 0033766151     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (7)

1. Treatment of progressing stroke
2. Heparin treatment in 52 patients with progressive ischemic stroke
3. Anticoagulation-induced intracerebral bleeding in brain ischmia
4. Low molecular weight heparin
5. Low-molecular-weight heparin for the treatment of acute ischemic stroke
6. Stroke-in-progression
7. Low molecular weight heparin - Clinical investigations and practical recommendations